Procedure evidence2025 · Ng CPY et al.
TULA for recurrent NMIBC: long-term outcomes
Long-term outcome of transurethral laser ablation for recurrent non-muscle invasive bladder cancer: An EORTC risk-matched study
BJUI compass
Findings: The study reported a 4% complication rate in a predominantly older population with comorbidities. Progression and recurrence risks were assessed by EORTC group.
Points to consider: Five-year recurrence remained high. A single-center study without randomized comparison; it does not establish TULA as a replacement for TURBT in all patients. One author received biolitec educational funding.
Device & relevance: Dual 1470/980 nm diode laser; no model name stated in the methods reviewed.